Waning immunity, prevailing non-vaccine type <i>ptxP3</i> and macrolide-resistant strains in the 2024 pertussis outbreak in China: a multicentre cross-sectional descriptive study.

Lancet Reg Health West Pac · 2025 · PMC12272891 · PMID 40688167

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The overwhelming dominance of the MT28 variant with non-vaccine type ptxP 3 and an increasing trend of PRN-deficient B. pertussis isolates circulating in China support the speculation of the existence of vaccine escape.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Waning immunity, prevailing non-vaccine type &lt;i&gt;ptxP3&lt;/i&gt; and macrolide-resistant strains in the 2024 pertussis outbreak in China: a multicentre cross-sectional descriptive study.

The sentences

Waning immunity, prevailing non-vaccine type <i>ptxP3</i> and macrolide-resistant strains in the 2024 pertussis outbreak in China: a multicentre cross-sectional descriptive study.